Literature DB >> 7805694

Development of resistance to macrolide antibiotics in an AIDS patient treated with clarithromycin for Campylobacter jejuni diarrhea.

G Funke1, R Baumann, J L Penner, M Altwegg.   

Abstract

In an AIDS patient with diarrhea, identical isolates of Campylobacter jejuni susceptible and, later, resistant to macrolide antibiotics were isolated from feces before and after treatment with clarithromycin. Results of rRNA gene restriction analysis and serotyping suggest that development of resistance rather than simultaneous infection with a susceptible and a resistant strain was responsible for this phenomenon. This is the first report of in vivo development of resistance by Campylobacter jejuni in a patient treated with a macrolide for Campylobacter jejuni infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7805694     DOI: 10.1007/bf01971317

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

1.  Results of the first year of national surveillance of Campylobacter infections in the United States.

Authors:  L W Riley; M J Finch
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

2.  Diarrhea and Campylobacter infections in patients infected with the human immunodeficiency virus.

Authors:  E Bernard; P M Roger; D Carles; V Bonaldi; J P Fournier; P Dellamonica
Journal:  J Infect Dis       Date:  1989-01       Impact factor: 5.226

3.  Persistent Campylobacter jejuni infections in patients infected with the human immunodeficiency virus (HIV).

Authors:  D M Perlman; N M Ampel; R B Schifman; D L Cohn; C M Patton; M L Aguirre; W L Wang; M J Blaser
Journal:  Ann Intern Med       Date:  1988-04       Impact factor: 25.391

4.  Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens.

Authors:  J L Penner; J N Hennessy
Journal:  J Clin Microbiol       Date:  1980-12       Impact factor: 5.948

5.  rRNA gene restriction patterns and plasmid analysis as a tool for typing Salmonella enteritidis.

Authors:  G Martinetti; M Altwegg
Journal:  Res Microbiol       Date:  1990 Nov-Dec       Impact factor: 3.992

6.  In vitro susceptibility of quinolone-resistant Campylobacter jejuni to new macrolide antibiotics.

Authors:  H P Endtz; M Broeren; R P Mouton
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-01       Impact factor: 3.267

7.  In vitro susceptibilities of Campylobacter jejuni and Campylobacter coli to azithromycin and erythromycin.

Authors:  D E Taylor; N Chang
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

8.  Persistence of multiply antibiotic-resistant Campylobacter jejuni in a patient with the acquired immune deficiency syndrome.

Authors:  B Dworkin; G P Wormser; R A Abdoo; F Cabello; M E Aguero; S L Sivak
Journal:  Am J Med       Date:  1986-05       Impact factor: 4.965

9.  Genome maps of Campylobacter jejuni and Campylobacter coli.

Authors:  D E Taylor; M Eaton; W Yan; N Chang
Journal:  J Bacteriol       Date:  1992-04       Impact factor: 3.490

10.  A new selective medium for the isolation of Campylobacter jejuni from human faeces.

Authors:  H Goossens; M De Boeck; J P Butzler
Journal:  Eur J Clin Microbiol       Date:  1983-08       Impact factor: 3.267

View more
  4 in total

1.  Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype.

Authors:  Amera Gibreel; Veronica N Kos; Monika Keelan; Cathy A Trieber; Simon Levesque; Sophie Michaud; Diane E Taylor
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

2.  PCR-restriction fragment length polymorphism analysis for detection of point mutations associated with macrolide resistance in Campylobacter spp.

Authors:  Sylvie Vacher; Armelle Ménard; Elisabeth Bernard; Francis Mégraud
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

3.  Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.

Authors:  J Engberg; F M Aarestrup; D E Taylor; P Gerner-Smidt; I Nachamkin
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

4.  Campylobacter antimicrobial resistance in Peru: a ten-year observational study.

Authors:  Simon Pollett; Claudio Rocha; Rito Zerpa; Lilian Patiño; Augusto Valencia; Máximo Camiña; José Guevara; Martha Lopez; Nancy Chuquiray; Eduardo Salazar-Lindo; Carlos Calampa; Martín Casapia; Rina Meza; Maruja Bernal; Drake Tilley; Michael Gregory; Ryan Maves; Eric Hall; Franca Jones; C Sofia Arriola; Marieke Rosenbaum; Juan Perez; Matthew Kasper
Journal:  BMC Infect Dis       Date:  2012-08-16       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.